KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Assets: 2010-2024

Historic Assets for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $38.8 million.

  • TherapeuticsMD's Assets fell 2.23% to $38.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.7 million, marking a year-over-year decrease of 2.23%. This contributed to the annual value of $38.8 million for FY2024, which is 10.36% down from last year.
  • TherapeuticsMD's Assets amounted to $38.8 million in FY2024, which was down 10.36% from $43.3 million recorded in FY2023.
  • TherapeuticsMD's Assets' 5-year high stood at $181.6 million during FY2020, with a 5-year trough of $38.8 million in FY2024.
  • In the last 3 years, TherapeuticsMD's Assets had a median value of $43.3 million in 2023 and averaged $57.5 million.
  • Data for TherapeuticsMD's Assets shows a maximum YoY crashed of 52.12% (in 2023) over the last 5 years.
  • Over the past 5 years, TherapeuticsMD's Assets (Yearly) stood at $181.6 million in 2020, then declined by 6.68% to $169.5 million in 2021, then crashed by 46.62% to $90.5 million in 2022, then slumped by 52.12% to $43.3 million in 2023, then dropped by 10.36% to $38.8 million in 2024.